US 8481095
Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosporylation of mitogen-activated protein kinase using flemingia macrophylla extract
granted A61KA61K2236/333A61K2800/782
Quick answer
US patent 8481095 (Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosporylation of mitogen-activated protein kinase using flemingia macrophylla extract) held by China Medical University expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- China Medical University
- Grant date
- Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2236/333, A61K2800/782, A61K36/48, A61K8/9789